Drugmakers do not have to sell orphan drugs to rural and cancer hospitals at a discount under the federal program known as 340B, a judge ruled Wednesday. The pharmaceutical industry's victory in the case disappointed many hospitals. READ MORE
|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, October 16, 2015
Judge sides with drugmakers and narrows 340B drug discounts
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment